skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


This content will become publicly available on December 1, 2026

Title: Gut bacteria induce heterologous immune priming in Rhodnius prolixus encompassing both humoral and cellular immune responses
Insects lack the adaptive, antibody mediated responses of vertebrates, yet they possess a robust innate immune system capable of defending themselves against pathogens. Immune priming has been observed in multiple insect species, wherein exposure to a pathogen provides protection against subsequent infections by the pathogen. Heterologous immune priming has also been described, where presence of one bacterial species provides protection against another. We determined thatRhodococcus rhodnii, a gut symbiont of the kissing bugRhodnius prolixus,induces strong heterologous immune priming, while axenic bugs lacking gut bacteria are highly susceptible to pathogens. CommensalEscherichia coliprovides less robust protection.R. rhodniimust be alive within the insect as dead bacteria do not stimulate immune priming and pathogen resistance. Removal ofR. rhodniifrom the gut reduces resistance to pathogens while restoring it to axenic bugs improves pathogen resistance, though not completely. Unlike most other examples of symbiont-mediated immune priming, we find no evidence thatR. rhodniiever leaves the gut, despite activating a potent immune response in the hemocoel and fat body.R. rhodniiandE. coliactivate both the IMD and Toll pathways indicating cross-activation of the pathways, while silencing of either pathway leads to a loss of the protective effect. Several antimicrobial peptides are induced in the fat body by presence of gut bacteria. WhenE. coliis in the gut, expression of antimicrobial peptides is often higher than whenR. rhodniiis present, whileR. rhodniiinduces proliferation of hemocytes and induces a stronger melanization response thanE. coli. Hemolymph fromR. rhodniibugs has a greater ability to convert the melanin precursor DOPA to melanization products than axenic orE. coli-harboring bugs. These results demonstrate thatR. rhodnii’sbenefits to its host extend beyond nutritional provisioning, playing an important role in the host immune system.  more » « less
Award ID(s):
2239595
PAR ID:
10660069
Author(s) / Creator(s):
; ; ;
Editor(s):
Vale, Pedro F
Publisher / Repository:
Public Library of Science
Date Published:
Journal Name:
PLOS Pathogens
Volume:
21
Issue:
12
ISSN:
1553-7374
Page Range / eLocation ID:
e1012947
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Summary High temperatures (e.g., fever) and gut microbiota can both influence host resistance to infection. However, effects of temperature‐driven changes in gut microbiota on resistance to parasites remain unexplored. We examined the temperature dependence of infection and gut bacterial communities in bumble bees infected with the trypanosomatid parasiteCrithidia bombi. Infection intensity decreased by over 80% between 21 and 37°C. Temperatures of peak infection were lower than predicted based on parasite growthin vitro, consistent with mismatches in thermal performance curves of hosts, parasites and gut symbionts. Gut bacterial community size and composition exhibited slight but significant, non‐linear, and taxon‐specific responses to temperature. Abundance of total gut bacteria and of Orbaceae, both negatively correlated with infection in previous studies, were positively correlated with infection here. Prevalence of the bee pathogen‐containing family Enterobacteriaceae declined with temperature, suggesting that high temperature may confer protection against diverse gut pathogens. Our results indicate that resistance to infection reflects not only the temperature dependence of host and parasite performance, but also temperature‐dependent activity of gut bacteria. The thermal ecology of gut parasite‐symbiont interactions may be broadly relevant to infectious disease, both in ectothermic organisms that inhabit changing climates, and in endotherms that exhibit fever‐based immunity. 
    more » « less
  2. Abstract Gut symbionts can augment resistance to pathogens by stimulating host-immune responses, competing for space and nutrients, or producing antimicrobial metabolites. Gut microbiota of social bees, which pollinate many crops and wildflowers, protect hosts against diverse infections and might counteract pathogen-related bee declines. Bumble bee gut microbiota, and specifically abundance of Lactobacillus ‘Firm-5’ bacteria, can enhance resistance to the trypanosomatid parasite Crithidia bombi . However, the mechanism underlying this effect remains unknown. We hypothesized that the Firm-5 bacterium Lactobacillus bombicola , which produces lactic acid, inhibits C. bombi via pH-mediated effects. Consistent with our hypothesis, L. bombicola spent medium inhibited C. bombi growth via reduction in pH that was both necessary and sufficient for inhibition. Inhibition of all parasite strains occurred within the pH range documented in honey bees, though sensitivity to acidity varied among strains. Spent medium was slightly more potent than HCl, d - and l -lactic acids for a given pH, suggesting that other metabolites also contribute to inhibition. Results implicate symbiont-mediated reduction in gut pH as a key determinant of trypanosomatid infection in bees. Future investigation into in vivo effects of gut microbiota on pH and infection intensity would test the relevance of these findings for bees threatened by trypanosomatids. 
    more » « less
  3. Discussions of host–microbe interactions in mosquito vectors are frequently dominated by a focus on the human pathogens they transmit (e.g.Plasmodiumparasites and arboviruses). Underlying the interactions between a vector and its transmissible pathogens, however, is the physiology of an insect living and interacting with a world of bacteria and fungi including commensals, mutualists and primary and opportunistic pathogens. Here we review what is known about the bacteria and fungi associated with mosquitoes, with an emphasis on the members of theAedesgenus. We explore the reciprocal effects of microbe on mosquito, and mosquito on microbe. We analyse the roles of bacterial and fungal symbionts in mosquito development, their effects on vector competence, and their potential uses as biocontrol agents and vectors for paratransgenesis. We explore the compartments of the mosquito gut, uncovering the regionalization of immune effectors and modulators, which create the zones of resistance and immune tolerance with which the mosquito host controls and corrals its microbial symbionts. We examine the anatomical patterning of basally expressed antimicrobial peptides. Finally, we review the relationships between inducible antimicrobial peptides and canonical immune signalling pathways, comparing and contrasting current knowledge on each pathway in mosquitoes to the model insectDrosophila melanogaster. This article is part of the theme issue ‘Sculpting the microbiome: how host factors determine and respond to microbial colonization’. 
    more » « less
  4. Many organisms use molecules called antimicrobial peptides as a first line of defense against harmful bacteria. For example, in humans, these natural antibiotics are found in the airways, on the skin and in the urinary tract. Because antimicrobial peptides are positively charged, they function in a different way compared to conventional antibiotics. They are attracted to the negatively charged surface of a bacterium, where they latch onto and penetrate through the membrane that encapsulates the microbe. While this mechanism is well studied at the molecular level, very little is known about how antimicrobial peptides spread and interact in a population of bacteria. Snoussi et al. combined several approaches to investigate the dynamics of antimicrobial peptides in Escherichia coli populations of varying densities. Experiments on single cells showed that peptides stopped the growth of bacteria, which were found to be more susceptible during the late stages of their life cycle. The dying cells then absorbed and retained a large number of antimicrobial peptides. This left fewer ‘free’ peptides that could target the other E. coli cells. In fact, when there were not enough peptides to kill all the bacteria, two sub-populations quickly emerged: one group that had stopped dividing – ‘soaking up’ the peptides – and another group that could grow unharmed. This new type of cooperation between threatened E. coli bacteria is passive, as it does not rely on any direct interactions between cells. The results by Snoussi et al. are relevant to medicine, because they highlight the relative importance for the body to produce enough new antimicrobial peptides to replenish the molecules trapped in bacteria. 
    more » « less
  5. Garsin, Danielle A. (Ed.)
    Innate immune priming increases an organism’s survival of a second infection after an initial, non-lethal infection. We usedDrosophila melanogasterand an insect-derived strain ofEnterococcus faecalisto study transcriptional control of priming. In contrast to other pathogens, the enhanced survival in primed animals does not correlate with decreasedE.faecalisload. Further analysis shows that primed organisms tolerate, rather than resist infection. Using RNA-seq of immune tissues, we found many genes were upregulated in only primed flies, suggesting a distinct transcriptional program in response to initial and secondary infections. In contrast, few genes continuously express throughout the experiment or more efficiently re-activate upon reinfection. Priming experiments in immune deficient mutants revealed Imd is largely dispensable for responding to a single infection but needed to fully prime. Together, this indicates the fly’s innate immune response is plastic—differing in immune strategy, transcriptional program, and pathway use depending on infection history. 
    more » « less